Variant report

Variant	rs6457932
Chromosome Location	chr6:36618140-36618141
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:36609340..36611035-chr6:36617549..36619389,2	K562	blood:
2	chr6:36591713..36594218-chr6:36617666..36619384,2	MCF-7	breast:
3	chr6:36618015..36619715-chr6:36627253..36629685,2	MCF-7	breast:
4	chr6:36597486..36599707-chr6:36615187..36618681,3	MCF-7	breast:
5	chr6:36611974..36613639-chr6:36617338..36618875,2	K562	blood:
6	chr6:36605328..36606866-chr6:36616080..36618764,2	K562	blood:
7	chr6:36615853..36625488-chr6:36645022..36649146,15	MCF-7	breast:
8	chr6:36617326..36619244-chr6:36622904..36626084,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000124762	Chromatin interaction

Extended variants
information (count: 33 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:30)

rs_ID	r²[population]
rs10456441	1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs10456442	1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs10456443	1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1059234	0.80[JPT][hapmap]
rs10947616	0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12203953	1.00[CEU][hapmap];0.86[CHB][hapmap];1.00[JPT][hapmap];0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs12206430	1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs12210094	1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12524435	1.00[CEU][hapmap];0.96[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12528248	0.86[JPT][hapmap]
rs12528913	0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs12530170	1.00[CEU][hapmap];0.91[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.93[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs1801270	0.85[JPT][hapmap]
rs3829963	0.95[JPT][hapmap];0.82[ASN][1000 genomes]
rs4464789	1.00[CEU][hapmap];0.91[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs4713993	1.00[CEU][hapmap];0.96[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6457934	0.84[ASN][1000 genomes]
rs6915170	0.91[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs6920453	1.00[CEU][hapmap];0.91[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.92[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs6931097	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs72853320	0.88[ASN][1000 genomes]
rs7382183	0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs7757749	0.86[JPT][hapmap]
rs7761648	0.86[JPT][hapmap]
rs876581	0.85[JPT][hapmap]
rs9349002	0.90[JPT][hapmap];0.89[ASN][1000 genomes]
rs9349003	0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9349005	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs9366912	1.00[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];0.93[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9394371	0.82[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv885806	chr6:36349890-36621178	Flanking Bivalent TSS/Enh Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
2	nsv1031191	chr6:36588974-36718015	Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
3	nsv538201	chr6:36588974-36718015	Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:36611600-36628600	Weak transcription	Right Atrium	heart
2	chr6:36613200-36618600	Weak transcription	Primary neutrophils fromperipheralblood	blood
3	chr6:36613200-36619600	Weak transcription	Placenta	Placenta
4	chr6:36613400-36625000	Weak transcription	Fetal Kidney	kidney
5	chr6:36616600-36618200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr6:36616800-36618800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr6:36616800-36619400	Enhancers	Breast Myoepithelial Primary Cells	Breast
8	chr6:36616800-36619400	Enhancers	Adipose Nuclei	Adipose
9	chr6:36617000-36618200	Enhancers	HSMM	muscle
10	chr6:36617000-36618600	Enhancers	GM12878-XiMat	blood
11	chr6:36617000-36618800	Enhancers	Cortex derived primary cultured neurospheres	brain
12	chr6:36617000-36618800	Enhancers	Skeletal Muscle Male	skeletal muscle
13	chr6:36617000-36618800	Enhancers	HSMMtube	muscle
14	chr6:36617000-36619200	Enhancers	Primary hematopoietic stem cells	blood
15	chr6:36617000-36619200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr6:36617000-36619200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr6:36617000-36619800	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr6:36617200-36618200	Enhancers	Muscle Satellite Cultured Cells	--
19	chr6:36617200-36620200	Enhancers	Rectal Mucosa Donor 31	rectum
20	chr6:36617200-36620400	Enhancers	Primary monocytes fromperipheralblood	blood
21	chr6:36617400-36618200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr6:36617400-36618200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr6:36617400-36618200	Enhancers	Colonic Mucosa	Colon
24	chr6:36617400-36618200	Enhancers	Spleen	Spleen
25	chr6:36617400-36618200	Enhancers	HMEC	breast
26	chr6:36617400-36618600	Enhancers	Fetal Muscle Trunk	muscle
27	chr6:36617400-36618800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr6:36617400-36619200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
29	chr6:36617400-36619200	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr6:36617400-36619400	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr6:36617400-36619400	Bivalent Enhancer	K562	blood
32	chr6:36617400-36619600	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr6:36617400-36620400	Enhancers	Primary B cells from cord blood	blood
34	chr6:36617400-36620400	Enhancers	Sigmoid Colon	Sigmoid Colon
35	chr6:36617400-36620600	Enhancers	Duodenum Mucosa	Duodenum
36	chr6:36617400-36621600	Enhancers	Fetal Intestine Large	intestine
37	chr6:36617400-36621600	Enhancers	Fetal Intestine Small	intestine
38	chr6:36617600-36618200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr6:36617600-36618200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr6:36617600-36618200	Enhancers	Lung	lung
41	chr6:36617600-36618200	Enhancers	HUVEC	blood vessel
42	chr6:36617600-36618600	Weak transcription	Thymus	Thymus
43	chr6:36617600-36618800	Enhancers	H1 Cell Line	embryonic stem cell
44	chr6:36617600-36618800	Enhancers	Esophagus	oesophagus
45	chr6:36617600-36618800	Enhancers	Hela-S3	cervix
46	chr6:36617600-36619000	Enhancers	Stomach Mucosa	stomach
47	chr6:36617600-36619200	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr6:36617600-36619800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
49	chr6:36617800-36618200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr6:36617800-36618600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links